Rapport Therapeutics, Inc. (RAPP)
26.07
+1.63
(+6.67%)
USD |
NASDAQ |
Nov 09, 16:00
26.03
-0.04
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics Market Cap : 1.254B for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 1.254B |
| November 06, 2026 | 1.175B |
| November 05, 2026 | 1.141B |
| November 04, 2026 | 1.247B |
| November 03, 2026 | 1.223B |
| November 02, 2026 | 1.208B |
| October 30, 2026 | 1.201B |
| October 29, 2026 | 1.161B |
| October 28, 2026 | 1.079B |
| October 27, 2026 | 1.321B |
| October 26, 2026 | 1.215B |
| October 23, 2026 | 1.243B |
| October 22, 2026 | 1.272B |
| October 21, 2026 | 1.202B |
| October 20, 2026 | 1.408B |
| October 19, 2026 | 1.372B |
| October 16, 2026 | 1.322B |
| October 15, 2026 | 1.418B |
| October 14, 2026 | 1.359B |
| October 13, 2026 | 1.390B |
| October 12, 2026 | 1.446B |
| October 09, 2026 | 1.470B |
| October 08, 2026 | 1.431B |
| October 07, 2026 | 1.480B |
| October 06, 2026 | 1.494B |
| Date | Value |
|---|---|
| October 05, 2026 | 1.544B |
| October 02, 2026 | 1.543B |
| October 01, 2026 | 1.574B |
| September 30, 2026 | 1.611B |
| September 29, 2026 | 1.583B |
| September 28, 2026 | 1.604B |
| September 25, 2026 | 1.626B |
| September 24, 2026 | 1.622B |
| September 23, 2026 | 1.637B |
| September 22, 2026 | 1.989B |
| September 21, 2026 | 1.902B |
| September 18, 2026 | 1.940B |
| September 17, 2026 | 2.012B |
| September 16, 2026 | 1.985B |
| September 15, 2026 | 2.047B |
| September 14, 2026 | 2.110B |
| September 11, 2026 | 2.092B |
| September 10, 2026 | 2.084B |
| September 09, 2026 | 2.105B |
| September 08, 2026 | 2.210B |
| September 04, 2026 | 2.195B |
| September 03, 2026 | 2.285B |
| September 02, 2026 | 2.335B |
| September 01, 2026 | 2.329B |
| August 31, 2026 | 2.334B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 679.07B |
| ANI Pharmaceuticals, Inc. | 1.552B |
| Corcept Therapeutics, Inc. | 8.205B |
| Veru, Inc. | 37.34M |
| Eli Lilly & Co. | 1.329T |
Market Cap Related Metrics
| PS Ratio | 61.74 |
| PEG Ratio | -0.4593 |
| Price to Book Value | 3.205 |
| Price | 26.07 |
| Earnings Yield | -12.17% |
| PEGY Ratio | -0.4593 |